Findings presented at the Clinical Trials on Alzheimers Disease 2025 Congress in San Diego in December 2025 from the EVOKE and EVOKE+ Phase III studies evaluating oral semaglutide in early Alzheimers disease did not meet the main cognitive endpoint despite biomarker signals underscoring the translational gap between metabolic modulation and the complex nature of neurodegenerative processes
384 In a randomized controlled trial, a total of 77 people with digestive complaints received either 500 mg of a standardized curcumin called Curcugen, which provided 50% curcuminoids, or a placebo daily for eight weeks
Research Applications: Metabolic Studies : Investigating how GLP-1 S influences insulin sensitivity , glucose metabolism , and lipid regulation to improve understanding of metabolic conditions like type 2 diabetes and insulin resistance
10.1562/0031-8655(2002)075 2.0.CO;2 24 MartyL.SialaW.SchwarzlnderM.FrickerM
These findings support adjunct GSH/NAC use as an immunotherapeutic in addition to well-established anti-viral and immunomodulatory treatments, leading to improved outcomes in conditions characterized by hindered immune control as a result of oxidative stress (Stanislaus et al., 2005
